Literature DB >> 17558968

Testosterone deficiency and the metabolic syndrome.

Bruno Lunenfeld1.   

Abstract

Evidence is presented to link components of the metabolic syndrome to testosterone deficiency and obesity. Testosterone deficiency in hypogonadism or testosterone deprivation in normo-gonadotropic men increases fat mass as well as fasting insulin levels. Testosterone supplementation (TS) in a dose dependent manner, increase lean body mass (LBM), reduces fat mass, body mass index (BMI) and waist hip ratio in both young and elderly hypogonadal men. A negative association between T and insulin resistance as well as impaired glucose intolerance has been demonstrated and in type 2 diabetic men TS improves metabolic parameters. TS improves most components of the metabolic syndrome and also reduces inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17558968     DOI: 10.1080/13685530701390800

Source DB:  PubMed          Journal:  Aging Male        ISSN: 1368-5538            Impact factor:   5.892


  10 in total

1.  The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.

Authors:  James T Dalton; Kester G Barnette; Casey E Bohl; Michael L Hancock; Domingo Rodriguez; Shontelle T Dodson; Ronald A Morton; Mitchell S Steiner
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-08-02       Impact factor: 12.910

Review 2.  The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health.

Authors:  Marià Alemany
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

Review 3.  Does a Hypertrophying Muscle Fibre Reprogramme its Metabolism Similar to a Cancer Cell?

Authors:  Henning Wackerhage; Ivan J Vechetti; Philipp Baumert; Sebastian Gehlert; Lore Becker; Richard T Jaspers; Martin Hrabě de Angelis
Journal:  Sports Med       Date:  2022-04-23       Impact factor: 11.928

4.  The Obesity Epidemic and Its Impact on Urologic Care.

Authors:  David Mobley; Neil Baum
Journal:  Rev Urol       Date:  2015

Review 5.  Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy.

Authors:  Amanda J Redig; Hidayatullah G Munshi
Journal:  Am J Med       Date:  2010-01       Impact factor: 4.965

6.  Long-term Safety of Testosterone and Growth Hormone Supplementation: A Retrospective Study of Metabolic, Cardiovascular, and Oncologic Outcomes.

Authors:  Enrique Ginzburg; Nancy Klimas; Chad Parvus; Jeff Life; Robert Willix; Michale J Barber; Alvin Lin; Florence Comite
Journal:  J Clin Med Res       Date:  2010-08-18

7.  Metabolic patterns in insulin-sensitive male hypogonadism.

Authors:  Giuseppina Fanelli; Federica Gevi; Antonio Belardo; Lello Zolla
Journal:  Cell Death Dis       Date:  2018-04-22       Impact factor: 8.469

8.  Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy.

Authors:  Mayarling Francisca Troncoso; Mario Pavez; Carlos Wilson; Daniel Lagos; Javier Duran; Sebastián Ramos; Genaro Barrientos; Patricio Silva; Paola Llanos; Carla Basualto-Alarcón; B Daan Westenbrink; Sergio Lavandero; Manuel Estrada
Journal:  Biol Res       Date:  2021-02-05       Impact factor: 5.612

9.  Testosterone Restoration by Enclomiphene Citrate in Men with Secondary Hypogonadism: Pharmacodynamics and Pharmacokinetics.

Authors:  Ronald Wiehle; Glenn R Cunningham; Nelly Pitteloud; Jenny Wike; Kuang Hsu; Gregory K Fontenot; Michele Rosner; Andrew Dwyer; Joseph Podolski
Journal:  BJU Int       Date:  2013-07-12       Impact factor: 5.588

Review 10.  Classic and Novel Sex Hormone Binding Globulin Effects on the Cardiovascular System in Men.

Authors:  Carla Basualto-Alarcón; Paola Llanos; Gerardo García-Rivas; Mayarling Francisca Troncoso; Daniel Lagos; Genaro Barrientos; Manuel Estrada
Journal:  Int J Endocrinol       Date:  2021-07-21       Impact factor: 2.803

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.